Written by :
Posted on :

January 17, 2023

Kolosis BIO Announces the Appointment of Charles Crockett as Area Vice President, East

Salt Lake City, Utah, January 17, 2023

Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Charles Crockett as Area Vice President of Sales, East.

“Charlie’s addition significantly elevates our sales leadership team,” said Keegan Begley, President at Kolosis. “Charlie possesses a track record of success building and leading sales teams both for spinal hardware and orthobiologics. He is not just a talented sales leader, but a strategic thinker and technology expert who will add value to the company far beyond his sales capacity. It is hard to imagine a more exciting hire for Kolosis BIO!”

Prior to joining Kolosis, Charles served as Area Sales Manager at NuVasive where he led a direct spine and biologics sales team in North Carolina. Prior to his role at NuVasive, he was an award-winning Biologics Regional Manager at Orthofix where he built and managed an independent sales network supporting MTF bone graft tissues.

“Kolosis BIO is uniquely positioned in the market to continue their accelerated growth and I look forward to being a part of the company’s next phase of development towards becoming a leader in the orthobiologics space,” said Charles Crockett. “I am excited to again partner with MTF and their industry-leading bone tissues.”

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit